Abstract:Sornsiri Yimlamai, Kanokpan Ruangnapa, Wanaporn Anuntaseree, Kantara Saelim, Pharsai Prasertsan, Kantisa Sirianansopa Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand Correspondence: Kanokpan Ruangnapa, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat-Yai, Songkhla, 90110, Thailand, Tel +66-74-451250-1, Fax +66-74-451250-3, Email Purpose: It is still unclear whether considering abnormal spirometry as a marker for disease control can help physicians adjust asthma controllers in children because of the scarcity of pediatric studies. We aimed to investigate the prevalence of abnormal spirometry in a selected pediatric asthmatic population and its effect on longitudinal outcomes. Patients and Methods: This retrospective cohort study was conducted at the Songklanagarind Hospital, Thailand. Children with asthma aged < 18 years were recruited for review if they attended the clinic and underwent acceptable spirometry with bronchodilator responsiveness (BDR) tests after receiving asthma treatment for at least 3 months between January 2011 and June 2022. Differences in baseline characteristics, atopic factors, asthma treatment, and outcomes were analyzed between the normal and abnormal spirometry groups over a 12-month post-spirometry period. Results: The mean age of the 203 enrolled patients was 10.9 ± 2.6 years. Abnormal spirometry, defined as airflow limitation or the presence of BDR, was observed in 58.1% of patients. No significant differences were observed in baseline characteristics, atopic factors, asthma treatment, or outcomes between the normal and abnormal spirometry groups. Further analysis of 107 patients with abnormal spirometry with symptom control revealed that physicians adjusted the asthma controller based on spirometry and symptoms in 84 and 23 patients, respectively. There was no significant difference in the loss of disease control over the 12-month post-spirometry period between the two groups. Conclusion: Abnormal spirometry was found in 58.1% of treated school-aged patients with asthma. Abnormal spirometry results were not associated with poor asthma outcomes during the 12-month follow-up. Both symptom-based and spirometry-based adjustments of asthma controllers resulted in comparable symptom control over a 12-month follow-up period in the selected population. Keywords: pulmonary function test, lung function test, childhood asthma, bronchodilator responsiveness Asthma is the most prevalent non-communicable respiratory disease in childhood, affecting 11–13% of children worldwide. 1 Besides symptom control and minimizing the future risk of exacerbations, preserving normal lung function is an important goal of long-term pediatric asthma care. 2 Impaired lung function in children with asthma is associated with an increased risk of chronic airflow obstruction and chronic obstructive pulmonary disease development in early adulthood. 2–4 Therefore, regular assessment of lung function is encouraged in monitoring children with asthma. 2,5 Spirometry is currently the standard tool for assessing lung function in children with asthma. Abnormal spirometry parameters (such as low forced expiratory volume in 1 s [FEV1], low ratio of FEV1 to forced vital capacity [FEV1/FVC], or low forced expiratory flow between 25% and 75% of vital capacity [FEF25–75%], which represents airway dysfunction), are considered predictors of disease severity and long-term prognosis of respiratory health. 3,4 Children with asthma with a lower FEV1 percentage are more likely to have more severe disease and are at a higher risk of exacerbation. 6,7 However, a significant portion of symptom-controlled patients with asthma still have abnormal lung function. 8–11 Airway reversibility is another characteristic feature of asthma that can be assessed via bronchodilator responsiveness (BDR) testing in children with asthma. 2,5 Besides its diagnostic purpose, the persistence of BDR is a marker of poor asthma control and predictive of a good response to inhaled corticosteroids (ICS). 12,13 Previous studies have reported evidence of airway reversibility in children with asthma with good asthma control or normal lung function. 14,15 These controversial findings affect the role of spirometry and BDR testing in asthma management. However, because of the scarcity of pediatric studies, it is still unclear whether, besides symptom assessment, considering abnormal lung function or the presence of BDR as another marker for disease control can help physicians adjust asthma controllers in children. Hence, we aimed to investigate the prevalence of abnormal spirometry results in -Abstract Truncated-

Comparative study of changes in airway size and its function in childhood asthma using bronchodilator reversibility test

Clinical significance of FEV0.5 and FEV0.75 in the determination of pulmonary function in children with bronchial asthma

[Analysis of Lung Function in Children with Respiratory Diseases and Its Clinical Application].

Changes of Eosinophils in Bronchoalveolar Lavage Fluid of Asthma in Children and the Modulation Effect of Montelukast

Small-Airway Function Variables in Spirometry, Fractional Exhaled Nitric Oxide, and Circulating Eosinophils Predicted Airway Hyperresponsiveness in Patients with Mild Asthma.

[A Study of Airway Reactivity and Nature of Chronic Asthmatic Bronchitis].

Correlation between fractional exhaled nitric oxide and small airway function in patients with bronchial asthma and its influencing factors

Sex Differences of Small Airway Function and Fractional Exhaled Nitric Oxide in Patients with Mild Asthma

Airway Inflammation, Bronchial Hyperresponsiveness, and Anti-Asthma Therapy Responses in Cough Variant Asthma and Classic Asthma with FEV1%≥80% Predicted

Circadian Rhythm and Variability of Large and Small Airway Spirometric Variables in Healthy Individuals

Application of bronchodilation test by tidal breathing in 0 ～ 6-year old children with airway hyper-responsive diseases

Quantitative CT Metrics for the Prediction of Therapeutic Effect in Asthma.

A Longitudinal Study of a Selected Pediatric Asthmatic Population with Normal and Abnormal Spirometry at Baseline: An Emphasis on Treatment Outcomes

Spirometric Changes in Bronchodilation Tests as Predictors of Asthma Diagnosis and Treatment Response in Patients with FEV1 ≥ 80% Predicted

The Value of Fractional Exhaled Nitric Oxide and Forced Mid-Expiratory Flow As Predictive Markers of Bronchial Hyperresponsiveness in Adults with Chronic Cough.

Assessment on the ownership and use of mosquito nets in Mozambique

Pulmonary function study of airway resistance change with different age in asthmatic patients

Diagnostic Value of Various Pulmonary Function Standards of Bronchodilation Test

Airway Hyper-Responsiveness and Small Airway Function in Children with Well-Controlled Asthma

Bronchodilator reversibility in asthma and COPD: findings from three large population studies

The value of small airway function parameters and fractional exhaled nitric oxide for predicting positive methacholine challenge test in asthmatics of different ages with FEV<sub>1</sub> 80% predicted